Dominant-negative inhibition of prion replication in transgenic mice

Immunoassay 0303 health sciences Polymorphism, Genetic PrPSc Proteins Prions Protein Conformation Immunoblotting Brain Mice, Transgenic 3. Good health Mice 03 medical and health sciences Calibration Animals Humans Protein Isoforms Transgenes Genes, Dominant Scrapie
DOI: 10.1073/pnas.182425299 Publication Date: 2002-10-01T16:58:07Z
ABSTRACT
Our discovery of dominant-negative inhibition of prion formation in cultured cells provided an explanation for the resistance of some sheep to scrapie and humans to Creutzfeldt–Jakob disease. To determine whether dominant-negative inhibition occurs in vivo , we produced transgenic (Tg) mice expressing prion protein (PrP) with either the Q167R or Q218K mutation alone or in combination with wild-type (wt) PrP. Tg(MoPrP,Q167R) Prnp 0/0 mice expressing mutant PrP at levels equal to non-Tg mice remained healthy for >550 days, indicating that inoculation with prions did not cause disease. Immunoblots of brain homogenates and histologic analysis did not reveal abnormalities. Tg(MoPrP,Q167R) Prnp +/+ mice expressing both mutant and wt PrP did not exhibit neurologic dysfunction, but their brains revealed low levels of the PrP pathogenic isoform (PrP Sc ), and sections showed numerous vacuoles and severe astrocytic gliosis at 300 days after inoculation. Both Tg(MoPrP,Q218K) Prnp 0/0 and Tg(MoPrP,Q218K) Prnp +/+ mice expressing high levels of the transgene product remained healthy for >300 days after inoculation. Neither PrP Sc nor neuropathologic changes were found. Our studies demonstrate that although dominant-negative inhibition of wt PrP Sc formation occurs, expression of the dominant-negative PrP at the same level as wt PrP does not prevent prion formation completely. However, expression of dominant-negative PrP alone had no deleterious effects on the mice and did not support prion propagation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (135)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....